Susquehanna International Group, LLP Theravance Biopharma, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$7.66 - $10.25 $88,856 - $118,900	11,600 New	11,600 $93,000
Q2 2023 Aug 11, 2023	SELL	$10.16 - $11.92 $149,352 - $175,224	-14,700 Reduced 55.68%	11,700 $121,000
Q1 2023 May 16, 2023	SELL	$9.87 - $11.44 $39,480 - $45,760	-4,000 Reduced 13.16%	26,400 $286,000
Q4 2022 Feb 14, 2023	SELL	$9.65 - $11.34 $1.27 Million - $1.49 Million	-131,500 Reduced 81.22%	30,400 $341,000
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $532,765 - $648,970	63,500 Added 64.53%	161,900 $1.64 Million

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $636M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.